Skip to main content
OpenTrials
Completed

NCT Number: NCT05064098

Interpretations and Predictions of Patient Reported Outcomes by Breast Cancer Patients

This study will assess how patients' long-term quality of life after different surgical approaches compares to their predicted quality of life.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Breast Cancer Breast Diseases Breast Neoplasms Neoplasms Neoplasms by Site Skin Diseases Skin and Connective Tissue Diseases

Age range

18 year and older

Sex eligibility

Female

Study type

Observational

Primary location

University of Colorado Hopspital

Aurora, Colorado, 80045, United States

About this study

This study will assess how patients' long-term quality of life after different surgical approaches compares to their predicted quality of life. It will also provide the research team with improved understanding of how patients interact with and prefer to receive QOL information. Improved understanding of patient predictions and perceptions of information display will allow us to incorporate predicted future PROs into the shared decision making process as well as allow us to provide this important information to patients in a meaningful way.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Pre-surgical female breast cancer patients
  • Female breast cancer survivors

Exclusion criteria

Treatment and study plan

Primary outcomes

  1. Predicted patient reported outcomes up to 1 year after

    Time frame: 12 months

    Predicted patient reported outcomes for each domain six-months and 1 year after breast surgery.

  2. Actual patient reported outcomes for each domain after surgery

    Time frame: 6 month

    Actual PRO scores for each domain six-months after surgery

  3. Compare predicted and actual outcomes

    Time frame: 12 months

    Comparison of predicted versus actual PRO scores in patients undergoing surgery

  4. Patients preferred method of communicating results

    Time frame: 12 months

    Patients' preferred means of receiving and communicating PRO results.

Sponsors and collaborators

Lead sponsor

University of Colorado, Denver

Other

Registry information

Important dates

Study start
2021
Primary completion
2026
Study completion
2026
First posted
Oct 1, 2021
Registry last updated
Jul 10, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.